A875 Cells

The A875 cell line is a human melanoma cell line derived from a metastatic site in a 40-year-old female. Exhibiting morphological and growth characteristics typical of malignant melanoma, A875 has been extensively utilized in oncological research, particularly focusing on melanoma biology, mechanisms of metastasis, and therapeutic resistance. This cell line is characterized by its aggressive growth and metastatic potential, making it an excellent model for in vivo tumor growth and metastasis studies in xenograft settings. A875 cells are particularly valuable for investigating the molecular and genetic underpinnings of melanoma progression. Research involving this cell line includes studies on the roles of oncogenes, tumor suppressor genes, and various signaling pathways that are pivotal in cancer development and progression. The cell line has been used in the assessment of novel chemotherapeutic agents and targeted therapies, benefiting from its genetic alterations that mimic those found in human melanomas. Furthermore, A875 serves as a key model for evaluating immune response mechanisms to melanoma, due to its ability to elicit strong immune reactions, thus aiding in the development and testing of new immunotherapies.